These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11205332)

  • 1. The reverse transcriptase model of somatic hypermutation.
    Steele EJ; Blanden RV
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):61-6. PubMed ID: 11205332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hypermutation of the 5' noncoding region in the BCL-6 gene.
    Wang L; Xu L; Jin X; Liu J; Huang W; Wang H; Wang J; Gu B; Yang W; Liu H; Chen Z; Chen S
    Chin Med J (Engl); 2001 Mar; 114(3):286-90. PubMed ID: 11780315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
    Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation.
    Zan H; Li Z; Yamaji K; Dramitinos P; Cerutti A; Casali P
    J Immunol; 2000 Jul; 165(2):830-9. PubMed ID: 10878357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation.
    Sale JE; Calandrini DM; Takata M; Takeda S; Neuberger MS
    Nature; 2001 Aug; 412(6850):921-6. PubMed ID: 11528482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymerase-eta as a reverse transcriptase: implications for mechanisms of hypermutation in innate anti-retroviral defences and antibody SHM systems.
    Steele EJ
    DNA Repair (Amst); 2004 Jul; 3(7):687-92. PubMed ID: 15177177
    [No Abstract]   [Full Text] [Related]  

  • 7. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proto-oncogene BCL-6 in normal and malignant B cell development.
    Niu H
    Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic hypermutation of immunoglobulin and non-immunoglobulin genes.
    Storb U; Shen HM; Michael N; Kim N
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):13-9. PubMed ID: 11205325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL-6: rearrangement and mutation in lymphoma.
    Wagner SD; Kaeda JS
    Methods Mol Med; 2005; 115():251-70. PubMed ID: 15998973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
    Jardin F; Sahota SS
    Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of BCL-6 gene expression by interferon-gamma and identification of an IRE in exon I.
    Zhou G; Ono SJ
    Exp Mol Pathol; 2005 Feb; 78(1):25-35. PubMed ID: 15596057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
    Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
    Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying protein-protein interactions in somatic hypermutation.
    Goodman MF; Scharff MD
    J Exp Med; 2005 Feb; 201(4):493-6. PubMed ID: 15710655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of factors affecting the onset and maturation course of follicular lymphoma through simulations of the germinal center.
    Fenwick MK; Escobedo FA
    Bull Math Biol; 2009 Aug; 71(6):1432-62. PubMed ID: 19412639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genesis of the strand-biased signature in somatic hypermutation of rearranged immunoglobulin variable genes.
    Steele EJ; Franklin A; Blanden RV
    Immunol Cell Biol; 2004 Apr; 82(2):209-18. PubMed ID: 15061776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs.
    Steele EJ
    Mol Immunol; 2009 Jan; 46(3):305-20. PubMed ID: 19062097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the reverse transcriptase model of somatic mutation.
    Sack SZ; Bardwell PD; Scharff MD
    Mol Immunol; 2001 Aug; 38(4):303-11. PubMed ID: 11566323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Akasaka, H., et al., Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res., 60: 2335-2341, 2000.
    Lossos IS; Jacobs Y; Cleary ML; Levy R
    Cancer Res; 2001 Oct; 61(19):7363-4. PubMed ID: 11585778
    [No Abstract]   [Full Text] [Related]  

  • 20. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation.
    Zan H; Komori A; Li Z; Cerutti A; Schaffer A; Flajnik MF; Diaz M; Casali P
    Immunity; 2001 May; 14(5):643-53. PubMed ID: 11371365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.